Comparison

Recombinant human SOST/Sclerostin protein

Item no. NKM-ATGP4011-50ug
Manufacturer NKMAX
Amount 50 ug
Quantity options 100 ug 10 ug 20 ug 250 ug 500 ug 50 ug
Category
Type Proteins Recombinant
Format Liquid
Applications SDS-PAGE
Specific against Human (Homo sapiens)
Host HEK293
Conjugate/Tag HIS
Purity > 95% by SDS - PAGE
Sequence <DGSM>QGWQAF KNDATEIIPE LGEYPEPPPE LENNKTMNRA ENGGRPPHHP FETKDVSEYS CRELHFTRYV TDGPCRSAKP VTELVCSGQC GPARLLPNAI GRGKWWRPSG PDFRCIPDRY RAQRVQLLCP GGEAPRARKV RLVASCKCKR LTRFHNQSEL KDFGTEAARP QKGRKPRPRA RSAKANQAEL ENAY<HHHHHH>
Citations Winkler DG, et al. (2003) The EMBO Journal. 22:6267–6276.
Li X, et al. (2005) The Journal of Biological Chemistry. 280:19883–19887.
NCBI NP_079513.1
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias SOST,Sclerostin,UNQ2976,PRO7455,PRO7476,CDD,VBCH,DAND6,SOST1
Available
Manufacturer - Type
Proteins
Manufacturer - Category
Recombinant Protein
Storage Conditions
Can be stored at +2C to +8C for 1 week. For long term storage, aliquot and store at -20C to -80C. Avoid repeated freezing and thawing cycles.
Molecular Weight
22.7kDa (200aa)
Description
SOST, also known as Sclerostin, is a member of the cerberus/DAN family. This protein is produced primarily by the osteocyte but is also expressed in other tissues, and has anti-anabolic effects on bone formation. It was originally believed to be a nonclassical bone morphogenetic protein (BMP) antagonist. More recently, sclerostin has been identified as binding to LRP5/6 receptors and inhibiting the Wnt signaling pathway. The inhibition of the Wnt pathway leads to decreased bone formation. Although the underlying mechanisms are unclear, it is believed that the antagonism of BMP-induced bone formation by sclerostin is mediated by Wnt signaling, but not BMP signaling pathways. Mutations in the gene that encodes the sclerostin protein are associated with disorders associated with high bone mass, sclerosteosis and van Buchem disease. Recombinant human SOST/Sclerostin, fused to His-tag at C-terminus, was expressed in HEK293 cell and purified by using conventional chromatography techniques.
Concentration
0.25mg/ml (determined by Bradford assay)
Formulation
Liquid. In Phosphate-Buffered Saline (pH 7.4) containing 30% glycerol
Antigen Species
Human
Gene Category
Signal Transduction
Domain
24-213aa
Endotoxin
< 1 EU per 1ug of protein (determined by LAL method)
Predicted nterm
Asp
Species of Protein
Human
Manufacturer - Search Terms
ATGP4011-10ug, ATGP4011-20ug, ATGP4011-50ug, ATGP4011-100ug, ATGP4011-250ug, ATGP4011-500ug, ATGP4011-1mg, ATGP4011-10, ATGP4011-20, ATGP4011-50, ATGP4011-100, ATGP4011-250, ATGP4011-500, ATGP4011-1, ATGP4011-10ug, ATGP4011-20ug, ATGP4011-50ug, ATGP4011-100ug, ATGP4011-250ug, ATGP4011-500ug, ATGP4011-1mg, ATGP4011-10, ATGP4011-20, ATGP4011-50, ATGP4011-100, ATGP4011-250, ATGP4011-500, ATGP4011-1
Manufacturer - Similar Names
ATGP4011-10ug, ATGP4011-20ug, ATGP4011-50ug, ATGP4011-100ug, ATGP4011-250ug, ATGP4011-500ug, ATGP4011-1mg, ATGP4011-10, ATGP4011-20, ATGP4011-50, ATGP4011-100, ATGP4011-250, ATGP4011-500, ATGP4011-1, ATGP4011-10ug, ATGP4011-20ug, ATGP4011-50ug, ATGP4011-100ug, ATGP4011-250ug, ATGP4011-500ug, ATGP4011-1mg, ATGP4011-10, ATGP4011-20, ATGP4011-50, ATGP4011-100, ATGP4011-250, ATGP4011-500, ATGP4011-1

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 ug
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close